Abstract:Inflammasomes are assembled by innate immune sensors that cells employ to detect a range of danger signals and respond with pro-inflammatory signalling. Inflammasomes activate inflammatory caspases, which trigger a cascade of molecular events with the potential to compromise cellular integrity and release the IL-1β and IL-18 pro-inflammatory cytokines. Several molecular mechanisms, working in concert, ensure that inflammasome activation is tightly regulated; these include NLRP3 post-translational modifications, ubiquitination and phosphorylation, as well as single-domain proteins that competitively bind to key inflammasome components, such as the CARD-only proteins (COPs) and PYD-only proteins (POPs). These diverse regulatory systems ensure that a suitable level of inflammation is initiated to counteract any cellular insult, while simultaneously preserving tissue architecture. When inflammasomes are aberrantly activated can drive excessive production of pro-inflammatory cytokines and cell death, leading to tissue damage. In several autoinflammatory conditions, inflammasomes are aberrantly activated with subsequent development of clinical features that reflect the degree of underlying tissue and organ damage. Several of the resulting disease complications may be successfully controlled by anti-inflammatory drugs and/or specific cytokine inhibitors, in addition to more recently developed small-molecule inhibitors. In this review, we will explore the molecular processes underlying the activation of several inflammasomes and highlight their role during health and disease. We also describe the detrimental effects of these inflammasome complexes, in some pathological conditions, and review current therapeutic approaches as well as future prospective treatments.

Regulatory Roles of the Caspase-11 Non-Canonical Inflammasome in Inflammatory Diseases

Roles of the Caspase-11 Non-Canonical Inflammasome in Rheumatic Diseases

Regulation, Activation and Function of Caspase-11 during Health and Disease

Activation and Pharmacological Regulation of Inflammasomes

Non-canonical inflammasome activation targets caspase-11

Caspase-1: The inflammasome and beyond

The Role of Caspase-11 in the Immune Inflammatory Response

Regulatory Roles of Flavonoids on Inflammasome Activation during Inflammatory Responses

Inflammasomes: mechanism of action, role in disease, and therapeutics

Inflammasome activation: from molecular mechanisms to autoinflammation

Mechanisms and Consequences of Noncanonical Inflammasome-Mediated Pyroptosis

Noncanonical inflammasomes: Antimicrobial defense that does not play by the rules

The role of inflammasomes in human diseases and their potential as therapeutic targets

Inflammasomes: Key Mediators of Lung Immunity

Inflammasomes and their roles in health and disease

The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases

Inflammasomes as therapeutic targets in human diseases

Inflammasomes: Molecular Regulation and Implications for Metabolic and Cognitive Diseases

Role of Inflammasomes in Kidney Diseases via Both Canonical and Non-canonical Pathways

Converging roles of caspases in inflammasome activation, cell death and innate immunity

Focus on the Mechanisms and Functions of Pyroptosis, Inflammasomes, and Inflammatory Caspases in Infectious Diseases